Literature DB >> 22180583

Assessing the role of attention-deficit/hyperactivity disorder symptoms in smokers with and without posttraumatic stress disorder.

John T Mitchell1, Elizabeth E Van Voorhees, Michelle F Dennis, F Joseph McClernon, Patrick S Calhoun, Scott H Kollins, Jean C Beckham.   

Abstract

INTRODUCTION: Smoking prevalence among individuals with posttraumatic stress disorder (PTSD) is elevated relative to non-PTSD smokers, and there is evidence to suggest that affect regulation may be a motivation for smoking among those with this disorder. Previous studies have also indicated that (a) PTSD is frequently comorbid with attention-deficit/hyperactivity disorder (ADHD), (b) individuals with ADHD smoke at significantly higher rates than the general population, (c) subclinical ADHD symptoms are a risk factor for smoking, and (d) affect regulation is a motivation for smoking in ADHD. The goal of this study was to assess the degree to which ADHD symptoms were uniquely associated with smoking-related affective functioning (SRAF) variables above and beyond the variance already explained by PTSD symptoms.
METHODS: Smokers with (n = 55) and without PTSD (n = 68) completed measures assessing PTSD symptoms, ADHD symptoms, and SRAF.
RESULTS: The PTSD group endorsed significantly more severe levels of DSM-IV inattentive and hyperactive-impulsive ADHD symptoms. A series of hierarchical regressions among the entire sample indicated that, after accounting for PTSD symptoms, ADHD symptoms were associated with lower positive affect, higher negative affect, higher emotion dysregulation, higher anxiety sensitivity, and higher urges to smoke to increase positive affect.
CONCLUSIONS: Taken together, these findings suggest that ADHD symptoms may increase affective dysregulation difficulties already faced by smokers, particularly those with PTSD, which may, in turn, confer increased risk for smoking relapse in those with higher levels of symptomatology of both disorders.

Entities:  

Mesh:

Year:  2011        PMID: 22180583      PMCID: PMC3439866          DOI: 10.1093/ntr/ntr245

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  36 in total

1.  Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study.

Authors:  Subin Park; Maeng Je Cho; Sung Man Chang; Hong Jin Jeon; Seong-Jin Cho; Byung-Soo Kim; Jae Nam Bae; Hee-Ryung Wang; Joon Ho Ahn; Jin Pyo Hong
Journal:  Psychiatry Res       Date:  2010-08-19       Impact factor: 3.222

2.  ADHD and comorbid disorders in relation to family environment and symptom severity.

Authors:  Tuula Hurtig; Hanna Ebeling; Anja Taanila; Jouko Miettunen; Susan Smalley; James McGough; Sandra Loo; Marjo-Riitta Järvelin; Irma Moilanen
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-03-30       Impact factor: 4.785

3.  Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder.

Authors:  Ake T Lu; Matthew N Ogdie; Marjo-Ritta Järvelin; Irma K Moilanen; Sandra K Loo; James T McCracken; James J McGough; May H Yang; Leena Peltonen; Stanley F Nelson; Rita M Cantor; Susan L Smalley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

4.  Posttraumatic stress disorder and smoking relapse: A theoretical model.

Authors:  Jessica W Cook; Miles M McFall; Patrick S Calhoun; Jean C Beckham
Journal:  J Trauma Stress       Date:  2007-12

5.  The validity and diagnostic efficiency of the Davidson Trauma Scale in military veterans who have served since September 11th, 2001.

Authors:  Scott D McDonald; Jean C Beckham; Rajendra A Morey; Patrick S Calhoun
Journal:  J Anxiety Disord       Date:  2008-08-06

6.  Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among ChildrenWith AD/HD.

Authors:  Arthur D Anastopoulos; Taylor F Smith; Melanie E Garrett; Erin Morrissey-Kane; Nicole K Schatz; Jennifer L Sommer; Scott H Kollins; Allison Ashley-Koch
Journal:  J Atten Disord       Date:  2010-08-04       Impact factor: 3.256

Review 7.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population.

Authors:  Susan L Smalley; James J McGough; Irma K Moilanen; Sandra K Loo; Anja Taanila; Hanna Ebeling; Tuula Hurtig; Marika Kaakinen; Lorie A Humphrey; James T McCracken; Teppo Varilo; May H Yang; Stanley F Nelson; Leena Peltonen; Marjo-Riitta Järvelin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-12       Impact factor: 8.829

Review 9.  Research review: a new perspective on attention-deficit/hyperactivity disorder: emotion dysregulation and trait models.

Authors:  Michelle M Martel
Journal:  J Child Psychol Psychiatry       Date:  2009-06-05       Impact factor: 8.982

10.  Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis.

Authors:  Lirio S Covey; Jeanne Manubay; Huiping Jiang; Mariel Nortick; Domenica Palumbo
Journal:  Nicotine Tob Res       Date:  2008-12       Impact factor: 4.244

View more
  3 in total

1.  Smoking motivation in adults with attention-deficit/hyperactivity disorder using the Wisconsin inventory of smoking dependence motives.

Authors:  John T Mitchell; Elizabeth M McIntyre; F Joseph McClernon; Scott H Kollins
Journal:  Nicotine Tob Res       Date:  2013-09-28       Impact factor: 4.244

2.  Posttraumatic stress disorder and tobacco use: A systematic review and meta-analysis.

Authors:  Irene Pericot-Valverde; Rebecca J Elliott; Mollie E Miller; Jennifer W Tidey; Diann E Gaalema
Journal:  Addict Behav       Date:  2018-05-03       Impact factor: 3.913

3.  Assessment of a conceptually informed measure of emotion dysregulation: Evidence of construct validity vis a vis impulsivity and internalizing symptoms in adolescents with ADHD.

Authors:  W John Monopoli; Steven W Evans; Kari Benson; Nicholas P Allan; Julie Sarno Owens; George J DuPaul; Nóra Bunford
Journal:  Int J Methods Psychiatr Res       Date:  2020-09-08       Impact factor: 4.035

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.